The Relative Strength (RS) Rating for Schrodinger climbed into a new percentile Friday, with a rise from 77 to 82.
Hone Your Stock-Picking Skills By Focusing On These Factors
IBD's proprietary RS Rating identifies market leadership by showing how a stock's price movement over the last 52 weeks measures up against that of the other stocks in our database.
History reveals that the top-performing stocks tend to have an 80 or better RS Rating as they begin their biggest runs.
Schrodinger is working on a cup with handle with a 27.27 buy point. See if it can clear the breakout price in volume at least 40% above average.
The company posted 0% earnings growth in the latest quarterly report, while sales growth came in at 63%.
Schrodinger holds the No. 6 rank among its peers in the Medical-Research Equipment/Services industry group. Fulgent Genetics, Schrodinger and Tempus AI are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
